Table 1.
Clinical characteristics of patients according to albumin in patients with DLBCL.
| Characteristics | Total | Albumin | P-value | |
|---|---|---|---|---|
| Low | High | |||
| Gender | 0.649 | |||
| Female | 228(32.7%) | 144(40.4%) | 84(38.5%) | |
| Male | 346(60.3%) | 212(59.6%) | 134(61.5%) | |
| Age | 0.021 | |||
| ≤60y | 456(79.4%) | 272(76.4%) | 184(84.4%) | |
| >60y | 118(20.6%) | 84(23.6%) | 34(15.6%) | |
| Performance status | 0.039 | |||
| 0–1 | 442(77.0%) | 264(74.2%) | 178(81.7%) | |
| 2–4 | 132(23.0%) | 92(25.8%) | 40(18.3%) | |
| B symptoms | <0.001 | |||
| No | 412(71.8%) | 226(63.5%) | 186(85.3%) | |
| Yes | 162(28.2%) | 130(36.5%) | 32(14.7%) | |
| Extranodal sites | 0.034 | |||
| 0–1 | 294(51.2%) | 170(47.8%) | 124(56.9%) | |
| ≥2 | 280(48.8%) | 186(52.2%) | 94(43.1%) | |
| Ann Arbor stage | 0.029 | |||
| I/II | 210(36.3%) | 118(33.1%) | 92(42.2%) | |
| III/IV | 364(63.4%) | 238(66.9%) | 126(57.8%) | |
| Lactate dehydrogenase | <0.001 | |||
| Normal | 102(17.8%) | 46(12.9%) | 56(25.7%) | |
| Elevated | 472(82.2%) | 310(87.1%) | 162(74.3%) | |
| International prognostic index | <0.001 | |||
| 0–1 | 222(38.8%) | 120(33.7%) | 102(46.8%) | |
| 2 | 132(23.0%) | 80(22.5%) | 52(23.9%) | |
| 3 | 138(24.0%) | 94(26.4%) | 44(20.2%) | |
| 4–5 | 82(14.3%) | 62(17.4%) | 20(9.2%) | |
| Albumin | <0.001 | |||
| Low | 228(39.7%) | 172(48.3%) | 56(25.7%) | |
| High | 346(60.3%) | 184(51.7%) | 162(74.3%) | |
| Cell of origin | 0.146 | |||
| Germinal center B cell like | 168(32.6%) | 96(30.2%) | 74(36.4%) | |
| Non-germinal center B cell like | 348(67.4%) | 222(69.8%) | 126(63.6%) | |